Select Page

OCREVUS (ocrelizumab) injection, for intravenous use. Initial U.S. Approval: 2017

OCREVUS (ocrelizumab) injection, for intravenous use. Initial U.S. Approval: 2017

OCREVUS is a prescription medicine. OCREVUS is used for multiple sclerosis-MS treatment.
INDICATIONS AND USAGE
OCREVUS is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis.
DOSAGE FORMS & STRENGTHS
Injection: 300 mg/10 mL (30 mg/mL) in a single-dose vial.
Manufactured By: Genentech
Prescribing Information URL: Click Here

Procedure to buy OCREVUS ™ (ocrelizumab) injection?
To buy OCREVUS ™ (ocrelizumab) injection, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Ocrelizumab, sold under the brand name Ocrevus, is a pharmaceutical drug for the treatment of multiple sclerosis (MS). It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug. Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds.

In the US, ocrelizumab is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults or for the treatment of primary progressive MS, in adults. It is administered by intravenous infusion.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

OCREVUS (ocrelizumab) injection in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
OCREVUS (ocrelizumab) injection in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
OCREVUS (ocrelizumab) injection in North America – Mexico.
OCREVUS (ocrelizumab) injection in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
OCREVUS (ocrelizumab) injection in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
OCREVUS (ocrelizumab) injection in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
OCREVUS (ocrelizumab) injection in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
OCREVUS (ocrelizumab) injection in Australia and New Zealand.

For Indian Patient

Ani-Cancer OCREVUS (ocrelizumab) injection are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

OCREVUS (ocrelizumab) injection can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “OCREVUS (ocrelizumab) injection, for intravenous use. Initial U.S. Approval: 2017”

Your email address will not be published.

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.